FDA Issues Warning Letter to Rontis Hellas S.A.
December 24, 2024
December 24, 2024
WASHINGTON, Dec. 24 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Rontis Hellas S.A.:
* * *
To: Ms. Efi Soultou, CEO, Rontis Hellas S.A., Industrial Area of Larissa Larissa, 415 00 Thessaloniki, Greece
Dear Ms. Efi Soultou,
During an inspection of your firm located in Larissa, Thessaloniki, 415 00 Greece on July 22, 2024 through July 25, 2024, an investigator from the Uni . . .
* * *
To: Ms. Efi Soultou, CEO, Rontis Hellas S.A., Industrial Area of Larissa Larissa, 415 00 Thessaloniki, Greece
Dear Ms. Efi Soultou,
During an inspection of your firm located in Larissa, Thessaloniki, 415 00 Greece on July 22, 2024 through July 25, 2024, an investigator from the Uni . . .